Skip to content
Late-StageResearch compoundModerate evidence

Cerebrolysin

Injectable medicine made from pig brain tissue for stroke recovery and dementia; not approved in the US.

NootropicNeuroprotectiveRecoveryPeptideNeuroprotectionBDNFGlutamate
Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Pharmacology

ClassPeptide · Neuroprotection
Primary targetNeurotrophic factor (BDNF/NGF-like) mimicry
Targets3 receptor targets
EvidenceModerate evidence
Affected systemsBDNFGlutamate

Contents

Related comparisons

Cerebrolysin vs Cortexin

DETAILED OVERVIEW

What is Cerebrolysin?

Cerebrolysin is a medicine made from pig brain tissue and given as an injection (into a vein or a muscle): the tissue is broken down into peptides, meaning short protein chains, and free amino acids. In Europe it is used mainly to support recovery after a stroke and to treat dementia, for example Alzheimer's disease. It is prescription-only in Hungary, Austria, Poland and several other countries; it is not approved in the United States.

Its peptides act in a way similar to the natural substances that help nerve cells grow: researchers believe they protect nerve cells from damage caused by lack of oxygen and stimulate the formation of new nerve cells. Two clinical trials in stroke showed improvement in the acute phase and during rehabilitation. Dizziness, headache, nausea and agitation can occur, and if given too fast also flushing, sweating and palpitations, rarely an allergic reaction. It cannot be given in epileptic seizures or severe kidney failure, and there is not enough safety data for pregnancy and breastfeeding.

Mechanism

Neurotrophic + neuroprotective peptides

Route

i.v. / i.m. injection

Legal status

EU Rx (HU, AT)

Receptor profile

  • Neurotrophic factors (BDNF/NGF-like)Strong
  • Neuronal survival / plasticityModerate
  • Amyloid / apoptosisModerate

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Dizziness, vertigo and headache
  • Heat sensation, sweating, palpitations with too-rapid infusion
  • Agitation, restlessness, occasionally insomnia or sleep disturbance
  • Nausea, vomiting, loss of appetite, diarrhoea
  • Local injection-site reaction, flushing
  • Rare hypersensitivity/allergic reaction (rash, itching)

Contraindications · 6

  • Known hypersensitivity to the peptide preparation
  • Status epilepticus and grand mal seizures (may lower seizure threshold)
  • Severe renal impairment
  • Pregnancy and breastfeeding (insufficient safety data)
  • Concurrent antidepressants/MAO inhibitors: dose adjustment advised due to additive effects
  • Slow i.v./i.m. administration only; not to be mixed with balanced amino-acid infusions

Related Nootropics

Same therapeutic category

FAQ

FAQ

Cerebrolysin is a prescription-only injectable medicine derived from pig brain tissue, used in Europe mainly to support recovery after stroke and to treat dementia (such as Alzheimer's disease). It's a doctor-prescribed treatment backed by clinical trials, not an over-the-counter supplement.

Telegram

Have a question about Cerebrolysin?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeNootropic
Formulamixture
UpdatedOctober 14, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.